Quantcast

Latest Metered-dose inhaler Stories

2014-06-24 23:06:47

According to a new report from BCC Research, the global market for pulmonary drug delivery systems is expected to grow to $43.9 billion by 2018 with a compound annual growth rate (CAGR) of 6.2% from 2013 to 2018. The dry powder inhalers category is the fastest moving segment in this market, growing at a significant five-year CAGR of 12.5%. (PRWEB) June 24, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, PULMONARY DRUG DELIVERY SYSTEMS: TECHNOLOGIES AND GLOBAL...

2014-05-22 23:04:45

Markets Research Reports.biz added deep and professional market research reports on "Ovarian Cancer Therapeutics To 2020" analysis and overview. (PRWEB) May 22, 2014 “Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies”. The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carbonation and facilitate, which are used in combination for the treatment of...

2014-05-06 08:34:19

New low-energy sensor eliminates charging, while enhanced analytics identify worsening patients MADISON, Wis., May 6, 2014 /PRNewswire/ -- World Asthma Day -- Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced U.S. Food and Drug Administration 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor. http://photos.prnewswire.com/prnvar/20140506/84619 Propeller is a digital therapeutic...

2014-04-04 12:27:51

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6ctxcw/smoking_cessation ) has announced the addition of the "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Smoking cessation products are a better alternative for tobacco and cigarette addicts. Smoking cessation...

2014-03-10 23:04:07

The 47 billion-dollar worldwide respiratory device market continues to grow mainly due to the aging of the world population and increasing incidence of respiratory diseases, according to Kalorama Information in the new report “The World Market for Respiratory Devices.” New York, NY (PRWEB) March 10, 2014 The 47 billion-dollar worldwide respiratory device market continues to grow mainly due to the aging of the world population and increasing incidence of respiratory diseases, according...

2014-03-04 23:22:24

The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal - http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html. (PRWEB) March 04, 2014 The "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion...

2014-02-25 08:32:43

ALBANY, New York, February 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pulmonary Drug Delivery Systems Market(Products- Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications- Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global pulmonary drug delivery systems market was valued at USD 21.03billion in 2012 and is expected to grow...

2014-02-19 16:25:14

VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ -- An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization. On Feb. 25, FDA's Nonprescription Drugs Advisory Committee and Pulmonary Allergy Drugs Committee will host a joint meeting to consider a new...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...

2013-11-19 23:32:03

Achieve is conducting a safety and efficacy study on a new combination asthma treatment versus an inhaled treatment for adolescents and adult patients with asthma. Birmingham, Alabama (PRWEB) November 19, 2013 *To see if you qualify for this Asthma Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and you may receive compensation for...


Latest Metered-dose inhaler Reference Libraries

Nicotine Replacement Therapy
2013-03-04 16:06:28

Nicotine replacement therapy is the administration of nicotine by other means than smoking. This change in the way nicotine is delivered prevents the harmful effects of smoking and is usually used in smoking cessation. Types Nicotine replacement therapy can be administered in several forms. The type used depends on the patient and what fits into their lifestyle best. The forms available include: Nicotine patches – transdermal (through the skin) Nicotine gum – orally (through the...

More Articles (1 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related